Creation of human tumour cells with defined genetic elements
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
During malignant transformation, cancer cells acquire genetic mutations that override the normal mechanisms controlling cellular proliferation. Primary rodent cells are efficiently converted into tumorigenic cells by the coexpression of cooperating oncogenes. However, similar experiments with human cells have consistently failed to yield tumorigenic transformants, indicating a fundamental difference in the biology of human and rodent cells. The few reported successes in the creation of human tumour cells have depended on the use of chemical or physical agents to achieve immortalization, the selection of rare, spontaneously arising immortalized cells, or the use of an entire viral genome. We show here that the ectopic expression of the telomerase catalytic subunit (hTERT) in combination with two oncogenes (the simian virus 40 large-T oncoprotein and an oncogenic allele of H-ras) results in direct tumorigenic conversion of normal human epithelial and fibroblast cells. These results demonstrate that disruption of the intracellular pathways regulated by large-T, oncogenic ras and telomerase suffices to create a human tumor cell.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“expression of telomerase in conjunction with expression of simian virus 40 large T oncoprotein and an oncogenic allele of H-ras has been shown to promote tumorigenic conversion of normal human cells (28).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [28]
In the citing paper
“Interestingly, high telomerase expression, which is associated with long telomeres, is commonly found in adult stem/progenitor cell compartments, including the stem cells in hair follicles, whereas low telomerase expression has been detected in human fibroblasts and epithelial cells [115, 116].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [116]
In the citing paper
“In studies employing a p53 allele (R172P) capable of enforcing senescence but defective in apoptosis, dysfunctional telomeres strongly inhibited the spontaneous lymphomas and sarcomas to which p53-mutant mice normally succumb.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
In the citing paper
“However, the R172P allele was not as efficient as wild-type p53 in inhibiting chemically induced papillomas”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
In the citing paper
“suggesting that senescence was insufficient to block transformation of keratinocytes in this model (94).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Self-citationA survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
Ruley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206
Absence of cancer–associated changes in human fibroblasts immortalized with telomerase
Morales, C. P., Holt, S. E., Ouellette, M., Kaur, K. J., Yan, Y., Wilson, K. S., White, M. A., Wright, W. E., & Shay, J. W. (1999) · Nature Genetics · doi:10.1038/5063 · Cited by 803
Kim, N. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.13.2595 · Cited by 686
Jiang, X.-R., Jimenez, G., Chang, E., Frolkis, M., Kusler, B., Sage, M., Beeche, M., Bodnar, A. G., Wahl, G. M., Tlsty, T. D., et al. (1999) · Nature Genetics · doi:10.1038/5056 · Cited by 668
Research works printed but not linked: 1
- Kang, J.-S.et al. Involvement of tyrosine phosphorylation of p185c-erb/neu in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells. Mol. Carcinogen.21, 225–233 (1998). · DOI
Cited by
Items 901–1,000 of 1,011
Differential Proteome Analysis of Replicative Senescence in Rat Embryo Fibroblasts
Benvenuti, S., Cramer, R., Quinn, C. C., Bruce, J., Zvelebil, M., Corless, S., Bond, J., Yang, A., Hockfield, S., Burlingame, A. L., et al. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m100028-mcp200 · Cited by 47
Telomerase-directed molecular therapeutics
Keith, W. N., Bilsland, A. E., Evans, T. R. J., & Glasspool, R. M. (2002) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399402004507 · Cited by 57
Jose, C., Melser, S., Benard, G., & Rossignol, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4357 · Cited by 46
Soohoo, C., Shi, R., Lee, T. H., Huang, P., Lu, K. P., & Zhou, X. Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180174 · Cited by 56
Heeg, S., Hirt, N., Queisser, A., Schmieg, H., Thaler, M., Kunert, H., Quante, M., Goessel, G., von Werder, A., Harder, J., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2010.01796.x · Cited by 46
Self-citationMehra, K. K., Chang, M. C., Folkins, A. K., Raho, C. J., Lima, J. F., Yuan, L., Mehrad, M., Tworoger, S. S., Crum, C. P., & Saleemuddin, A. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.171 · Cited by 46
Queisser, A., Heeg, S., Thaler, M., von Werder, A., & Opitz, O. G. (2013) · Cancer Genetics · doi:10.1016/j.cancergen.2013.10.001 · Cited by 50
The N Terminus of the OB Domain of Telomere Protein TPP1 Is Critical for Telomerase Action
Grill, S., Tesmer, V. M., & Nandakumar, J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.012 · Cited by 49
Vonderheide, R. H., Kraynyak, K. A., Shields, A. F., McRee, A. J., Johnson, J. M., Sun, W., Chintakuntlawar, A. V., Pawlicki, J. M., Sylvester, A. J., McMullan, T., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003019 · Cited by 47
Douarre, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki514 · Cited by 52
Using cancer genetics to guide the selection of anticancer drug targets
Reddy, A., & Kaelin, W. G. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00178-9 · Cited by 48
Senescence and immortalization of human cells
Duncan, E. L., Wadhwa, R., & Kaul, S. C. (2000) · Biogerontology · doi:10.1023/a:1010000132671 · Cited by 50
Atypical glandular cells of undetermined significance
Soofer, S. B., & Sidawy, M. K. (2000) · Cancer · doi:10.1002/1097-0142(20000825)90:4<235::aid-cncr6>3.0.co;2-z · Cited by 57
Weitzman, J. B., & Yaniv, M. (1999) · Nature · doi:10.1038/22637 · Cited by 49
Oligonucleotide Therapeutics: A Step Forward
Gewirtz, A. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1809 · Cited by 46
High incidence of TERT mutation in brain tumor cell lines
Johanns, T. M., Fu, Y., Kobayashi, D. K., Mei, Y., Dunn, I. F., Mao, D. D., Kim, A. H., & Dunn, G. P. (2016) · Brain Tumor Pathology · doi:10.1007/s10014-016-0257-5 · Cited by 46
Song, L. L., Ponomareva, L. V., Shen, H., Duan, X., Alimirah, F., & Choubey, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008569 · Cited by 47
Antitumor Activity of Systemically Delivered Ribozymes Targeting Murine Telomerase RNA
Nosrati, M., Li, S., Bagheri, S., Ginzinger, D. G., Blackburn, E. H., Debs, R. J., & Kashani–Sabet, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0134 · Cited by 45
Li, Y., Buckhaults, P., Cui, X., & Tollefsbol, T. O. (2016) · Epigenomics · doi:10.2217/epi-2016-0024 · Cited by 46
Eichhorn, P. J. A., Creyghton, M. P., Wilhelmsen, K., van Dam, H., & Bernards, R. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030218 · Cited by 45
Long-term immunological memory against viruses
Effros, R. B. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00207-4 · Cited by 45
Deng, Q., Li, Y., Tedesco, D., Liao, R., Fuhrmann, G., & Sun, P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0054 · Cited by 52
Gordon, K., Ireland, H., Roberts, M., Steeghs, K., McCaul, J. A., MacDonald, D. G., & Parkinson, E. K. (2003) · PubMed · Cited by 50
Relevance and safety of telomerase for human tissue engineering
Klinger, R. Y., Blum, J. L., Hearn, B., Lebow, B., & Niklason, L. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508184103 · Cited by 45
Universal tumor antigens as targets for immunotherapy
Gordan, J. D., & Vonderheide, R. H. (2002) · Cytotherapy · doi:10.1080/146532402760271091 · Cited by 52
Chiral RuII‐PtIIComplexes Inducing Telomere Dysfunction against Cisplatin‐Resistant Cancer Cells
Xiong, K., Ouyang, C., Liu, J., Karges, J., Lin, X., Chen, X., Chen, Y., Wan, J., Ji, L., & Chao, H. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202204866 · Cited by 47
TERT Promoter Mutations and Telomerase in Melanoma
Guo, Y., Chen, Y., Zhang, L., Ma, L., Jiang, K., Yao, G., & Zhu, L. (2022) · Journal of Oncology · doi:10.1155/2022/6300329 · Cited by 57
Vetsika, E., Konsolakis, G., Aggouraki, D., Kotsakis, A. P., Papadimitraki, E., Christou, S., Menez-Jamet, J., Kosmatopoulos, K., Georgoulias, V., & Mavroudis, D. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1093-4 · Cited by 46
Patel, S. D., Isalan, M., Gavory, G., Ladame, S., Choo, Y., & Balasubramanian, S. (2004) · Biochemistry · doi:10.1021/bi048892t · Cited by 45
Gordon, K., Clouaire, T., Bao, X. X., Kemp, S. E., Xenophontos, M., de Las Heras, J. I., & Stancheva, I. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1351 · Cited by 44
“The calculated ratio of wild type H-RAS to mutant H-RAS mRNA at 50 pd and 100 pd was 1:12 and 1:14, respectively .”
BackgroundMethodInfluentialRoçi, I., Watrous, J. D., Lagerborg, K. A., Lafranchi, L., Lindqvist, A., Jain, M., & Nilsson, R. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.059 · Cited by 48
A genetic strategy to overcome the senescence of primary meningioma cell cultures
Baía, G. S., Slocum, A. L., Hyer, J. D., Misra, A., Sehati, N., VandenBerg, S. R., Feuerstein, B. G., Deen, D. F., McDermott, M. W., & Lal, A. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-9076-y · Cited by 45
Racek, T., Miše, N., Li, Z., Stoll, A., & Pützer, B. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500193200 · Cited by 52
Induction of intestinalization in human esophageal keratinocytes is a multistep process
Kong, J., Nakagawa, H., Isariyawongse, B. K., Funakoshi, S., Silberg, D. G., Rustgi, A. K., & Lynch, J. P. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn227 · Cited by 43
Mavrogiannou, E., Strati, A. D., Stathopoulou, A., Tsaroucha, E. G., Kaklamanis, L., & Lianidou, E. S. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.073015 · Cited by 50
Zhong, M., Lu, Z., & Foster, D. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205165 · Cited by 45
Telomerase: biology and phase I trials
Kèlland, L. R. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00226-6 · Cited by 47
Contributions of Myc to tumorigenesis
Lutz, W., Leon, J., & Eilers, M. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00036-7 · Cited by 177
Qian, D., Zhang, B., He, L., Cai, M., Mai, S., Liao, Y.-J., Liu, Y., Lin, M. C. M., Bian, X., Zeng, Y., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4163 · Cited by 46
Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway
Xi, L., Chen, G., Zhou, J., Xu, G., Wang, S.-G., Wu, P., Zhu, T., Zhang, A., Yang, W., Xu, Q., et al. (2006) · APOPTOSIS · doi:10.1007/s10495-006-5701-2 · Cited by 42
Staphylococcal Superantigens Stimulate Immortalized Human Adipocytes to Produce Chemokines
Vu, B. G., Gourronc, F. A., Bernlohr, D., Schlievert, P. M., & Klingelhutz, A. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077988 · Cited by 48
Involvement of Telomerase Reverse Transcriptase in Heterochromatin Maintenance
Maida, Y., Yasukawa, M., Okamoto, N., Ohka, S., Kinoshita, K., Totoki, Y., Ito, T. K., Minamino, T., Nakamura, H. K., Yamaguchi, S., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00093-14 · Cited by 42
AMPK 2 Suppresses Murine Embryonic Fibroblast Transformation and Tumorigenesis
Phoenix, K. N., Devarakonda, C. K. V., Fox, M. M., Stevens, L. E., & Claffey, K. P. (2012) · Genes & Cancer · doi:10.1177/1947601912452883 · Cited by 47
RalB directly triggers invasion downstream Ras by mobilizing the Wave complex
Zago, G., Veith, I., Singh, M. K., Fuhrmann, L., de Beco, S., Remorino, A., Takaoka, S., Palmeri, M., Berger, F., Brandon, N., et al. (2018) · eLife · doi:10.7554/elife.40474 · Cited by 43
Cagigas, M. L., Bryce, N. S., Ariotti, N., Brayford, S., Gunning, P. W., & Hardeman, E. C. (2021) · Nature Materials · doi:10.1038/s41563-021-01087-z · Cited by 41
Gertler, R., Rosenberg, R., Stricker, D., Werner, M., Lassmann, S., Ulm, K., Nekarda, H., & Siewert, J. (2002) · Cancer · doi:10.1002/cncr.10939 · Cited by 43
Kim, M. K., Kang, M. R., Nam, H. W., Bae, Y., Kim, Y. S., & Chung, I. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710065200 · Cited by 50
Kim, S., Nakagawa, H., Navaraj, A., Naomoto, Y., Klein–Szanto, A. J., Rustgi, A. K., & El‐Deiry, W. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2104 · Cited by 44
Telomerase immunity from bench to bedside: round one
Cortez-Gonzalez, X., & Zanetti, M. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-12 · Cited by 43
Richards, K. F., Guastafierro, A., Shuda, M., Toptan, T., Moore, P. S., & Chang, Y. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000287 · Cited by 49
Sleeping beauty: a novel cancer gene discovery tool
Dupuy, A. J., Jenkins, N. A., & Copeland, N. G. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl061 · Cited by 43
Zhang, Y. P., Nemunaitis, J. J., Kj, S., & Tong, A. W. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301331 · Cited by 44
Marcum, J. A. (2005) · International Studies in the Philosophy of Science · doi:10.1080/02698590500051076 · Cited by 43
Energetics of Quadruplex-Drug Recognition in Anticancer Therapy
Pagano, B., & Giancola, C. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907781662257 · Cited by 43
SMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways
Gubanova, E., Issaeva, N., Göktürk, C., Djureinovic, T., & Helleday, T. (2013) · Cell Cycle · doi:10.4161/cc.26660 · Cited by 47
The senescent microenvironment promotes the emergence of heterogeneous cancer stem-like cells
Castro‐Vega, L. J., Jouravleva, K., Ortíz-Montero, P., Liu-Bordes, W.-Y., Galeano, J. L., Romero, M. L., Popova, T. G., Bacchetti, S., Vernot, J., & Londoño‐Vallejo, A. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv101 · Cited by 45
Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?
Lee, W., & Kolesnick, R. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.06.017 · Cited by 44
Smith, D. L., Soria, J., Morat, L., Yang, Q., Sabatier, L., Liu, D. D., Nemr, R. A., Rashid, A., & Vauthey, J. (2004) · Annals of Surgical Oncology · doi:10.1007/bf02524345 · Cited by 42
CDK2 translational down-regulation during endothelial senescence
Freedman, D. A., & Folkman, J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.03.025 · Cited by 47
Cuenca, F., Moore, M. M., Johnson, K., Guyen, B., Cian, A. D., & Neidle, S. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.033 · Cited by 45
hTERT gene dosage correlates with telomerase activity in human lung cancer cell lines
Saretzki, G. C., Petersen, S., Petersen, I., Kölble, K., & von Zglinicki, T. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00644-9 · Cited by 50
Li, M., Lewis, B., Capuco, A. V., Laucirica, R., & Furth, P. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203271 · Cited by 42
Zhang, H. Y., Zhang, X., Chen, X., Thomas, D., Hormi-Carver, K. K., Elder, F. F. B., Spechler, S. J., & Souza, R. F. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90262.2008 · Cited by 43
Pieraccini, S., Masiero, S., Pandoli, O. G., Samorı́, P., & Spada, G. P. (2006) · Organic Letters · doi:10.1021/ol061115w · Cited by 42
Bazarov, A., Adachi, S., Li, S. F., Mateyak, M. K., Wei, S., & Sedivy, J. M. (2001) · PubMed · Cited by 47
Stress kinase signaling in cancer: fact or fiction?
Rennefahrt, U. E. E., Janakiraman, M., Öllinger, R., & Troppmair, J. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.08.003 · Cited by 43
Recent advances in the development of telomerase inhibitors for the treatment of cancer
Perry, P. J., & Jenkins, T. C. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.12.1981 · Cited by 43
Stromal EGF and IGF-I Together Modulate Plasticity of Disseminated Triple-Negative Breast Tumors
Castaño, Z., Marsh, T., Tadipatri, R., Kuznetsov, H. S., Al‐Shahrour, F., Paktinat, M., Greene-Colozzi, A., Nilsson, B., Richardson, A. L., & McAllister, S. S. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0041 · Cited by 44
How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization
J. Brock, E., Ji, K., J. Reiners, J., & R. Mattingly, R. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557515666151001154002 · Cited by 40
Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma
Gertler, R., Doll, D., Maak, M., Feith, M., & Rosenberg, R. (2008) · Cancer · doi:10.1002/cncr.23419 · Cited by 47
Proteomic identification of CD44 interacting proteins
Skandalis, S. S., Kozlova, I., Engström, U., Hellman, U., & Heldin, P. (2010) · IUBMB Life · doi:10.1002/iub.392 · Cited by 41
CD52 is a molecular target in advanced systemic mastocytosis
Hoermann, G., Blatt, K., Greiner, G., Putz, E. M., Berger, A., Herrmann, H., Cerny‐Reiterer, S., Gleixner, K. V., Walz, C., Höetzenecker, K., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-250894 · Cited by 41
Mei, F. C., Young, T. W., Liu, J., & Cheng, X. (2005) · The FASEB Journal · doi:10.1096/fj.05-4586fje · Cited by 41
Molecular alterations in sporadic breast cancer
Lerebours, F., & Lidereau, R. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00191-3 · Cited by 61
Luo, L. Y., Kim, E., Cheung, H. W., Weir, B. A., Dunn, G. P., Shen, R. R., & Hahn, W. C. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0407 · Cited by 52
Self-citationBernard, B., Fest, T., Prétet, J., & Mougin, C. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400796 · Cited by 49
TGF-β and cancer: Is Smad3 a repressor of hTERT gene?
Li, H., Xu, D., Toh, B., & Liu, J. (2006) · Cell Research · doi:10.1038/sj.cr.7310023 · Cited by 43
Telomeres, Telomerase, and Telomerase Inhibition: Clinical Implications for Cancer
Ahmed, A., & Tollefsbol, T. O. (2003) · Journal of the American Geriatrics Society · doi:10.1034/j.1601-5215.2002.51019.x · Cited by 41
Delhommeau, F., Thierry, A., Feneux, D., Lauret, E., Leclercq, E., Courtier, M. H., Sainteny, F., Vainchenker, W., & Griscelli, A. B. (2002) · Oncogene · doi:10.1038/sj.onc.1206054 · Cited by 49
Anisimov, V. N. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00262-7 · Cited by 41
Villa, R., Porta, C. D., Folini, M., Daidone, M. G., & Zaffaroni, N. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01343.x · Cited by 45
Lack of expression and function of erythropoietin receptors in the kidney
Elliott, S., Busse, L. A., Swift, S. E., McCaffery, I., Rossi, J. M., Kassner, P. D., & Begley, C. G. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr698 · Cited by 38
Activation of Ras Requires the ERM-Dependent Link of Actin to the Plasma Membrane
Sperka, T., Geißler, K. J., Merkel, U., Scholl, I., Rubio, I., Herrlich, P. A., & Morrison, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027511 · Cited by 47
Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer
Shaw, V., Naisbitt, D., Costello, E., Greenhalf, W., Park, B., Neoptolemos, J., & Middleton, G. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.92 · Cited by 40
Kerry, L. E., Pegg, E., Cameron, D. P., Budzak, J., Poortinga, G., Hannan, K. M., Hannan, R. D., & Rudenko, G. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005432 · Cited by 43
TERT, a promoter of CNS malignancies
Patel, B., Taiwo, R., Kim, A. H., & Dunn, G. P. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa025 · Cited by 44
Jiang, R., Cabras, G., Sheng, W., Zeng, Y., & Ooka, T. (2009) · Neoplasia · doi:10.1593/neo.09706 · Cited by 41
c-Myc, Genomic Instability and Disease
Kuttler, F., & Mai, S. (2006) · KARGER eBooks · doi:10.1159/000092507 · Cited by 43
Spectral karyotyping of the human colon cancer cell lines SW480 and SW620
Melcher, R., Steinlein, C., Feichtinger, W., Müller, C. R., Menzel, T., Lührs, H., Scheppach, W. M., & Schmid, M. (2000) · Cytogenetic and Genome Research · doi:10.1159/000015508 · Cited by 55
The Potent Oncogene NPM-ALK Mediates Malignant Transformation of Normal Human CD4+ T Lymphocytes
Zhang, Q., Wei, F., Wang, H. Y., Liu, X., Roy, D. B., Xiong, Q.-B., Jiang, S., Medvec, A. R., Danet-Desnoyers, G. A., Watt, C. D., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.08.030 · Cited by 43
Knockdown of hTERT by siRNA inhibits cervical cancer cell growth in vitro and in vivo
Shi, Y., Zhao, Q., Zhang, L., Du, W., Wang, X., He, X., Wu, S., & Li, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2493 · Cited by 42
Targeting of VEGF‐dependent transendothelial migration of cancer cells by bevacizumab
Prager, G. W., Lackner, E., Krauth, M., Unseld, M., Poettler, M., Laffer, S., Cerny‐Reiterer, S., Lamm, W. W., Kornek, G. V., Binder, B. R., et al. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.01.002 · Cited by 40
Telomere shortening and cell fates in mouse models of neoplasia
Artandi, S. E. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02222-5 · Cited by 40
Young, T. W., Mei, F. C., Liu, J., Bast, R. C., Kurosky, A., & Cheng, X. (2005) · Oncogene · doi:10.1038/sj.onc.1208753 · Cited by 39
Seigneurin-Venin, S., Bernard, V., & Tremblay, J. P. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301132 · Cited by 40
Telomerase inhibitors: targeting the vulnerable end of cancer?
Kèlland, L. R. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200008000-00001 · Cited by 43
Engström, W., Darbre, P. D., Eriksson, S., Gulliver, L., Hultman, T., Karamouzis, M. V., Klaunig, J. E., Mehta, R., Moorwood, K., Sanderson, J. T., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv030 · Cited by 42
Distinct Effects of EGFR Ligands on Human Mammary Epithelial Cell Differentiation
Mukhopadhyay, C., Zhao, X., Maroni, D. M., Band, V., & Naramura, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075907 · Cited by 41
Oncogenicity of DNA in vivo: Tumor induction with expression plasmids for activated H-ras and c-myc
Sheng, L., Cai, F., Zhu, Y., Pal, A., Athanasiou, M., Orrison, B., Blair, D. G., Hughes, S. H., Coffin, J. M., Lewis, A. M., et al. (2008) · Biologicals · doi:10.1016/j.biologicals.2007.11.003 · Cited by 35
The Generation and Characterization of a Cell Line Derived from a Sporadic Renal Angiomyolipoma
Arbiser, J. L., Yeung, R., Weiss, S. W., Arbiser, Z. K., Amin, M. B., Cohen, C., Frank, D., Mahajan, S., Herron, G. S., Yang, J., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61720-8 · Cited by 32
Metadata
- Authors
- Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Duke Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 1999-07-29
- Volume
- 400
- Issue
- 6743
- Pages
- 464-468
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1545398558
- Cited by
- 2,345
- References
- 31
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 28 · 2023: 42 · 2022: 36 · 2021: 51 · 2020: 44 · 2019: 55 · 2018: 57 · 2017: 48 · 2016: 72 · 2015: 84 · 2014: 92 · 2013: 98 · 2012: 82
- FWCI
- 85.16
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2026-04-15)
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- malignant transformation, telomerase reverse transcriptase, SV40 large T antigen, oncogene cooperation, cell immortalization, human epithelial cells, human fibroblasts
- MeSH terms
- Animals, Antigens, Polyomavirus Transforming, Cell Adhesion, Cell Division, Cell Line, Cell Transformation, Neoplastic, Cells, Cultured, DNA-Binding Proteins, Epithelial Cells, Fibroblasts, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasm Transplantation, Genes, ras, RNA, Telomere, Telomerase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.